公司控制权变更
Search documents
菲林格尔控股权要变,股价“提前”涨停
IPO日报· 2025-05-31 04:28
Core Viewpoint - Filinger Home Technology Co., Ltd. is undergoing a potential change in control as its actual controller, Ding Furu, is planning to transfer shares, which may lead to a shift in company governance [1][10]. Group 1: Company Overview - Filinger was listed in 2017 and primarily engages in the production and after-sales service of solid wood and composite flooring, with its main brand being "Filinger" [3]. - The largest shareholder is Filinger Holdings Limited, holding 28.04% of shares, while Ding Furu and his associates collectively own 44.56% [3]. Group 2: Financial Performance - The company's financial performance has been declining, with revenues from 2020 to 2024 recorded as 602 million, 782 million, 523 million, 395 million, and 336 million yuan, respectively. Net profits during the same period were 60.88 million, 20.33 million, 9.72 million, -24.18 million, and -37.31 million yuan [4]. - The decline in performance is attributed to reduced demand in the home decoration market due to real estate adjustments, increased competition, and high fixed costs that could not be diluted [4]. Group 3: Shareholder Actions - In early May, Filinger announced that its largest shareholder plans to reduce holdings by up to 10.66 million shares, accounting for 3% of the total share capital [5]. - Other executives, including the general manager and vice presidents, also plan to reduce their shareholdings during the specified period [6]. Group 4: Regulatory Issues - Ding Furu and the company faced regulatory scrutiny from the China Securities Regulatory Commission for failing to disclose related party transactions properly, which involved significant contract amounts relative to the company's net assets [8][9].
易明医药: 2025-033 关于筹划公司控制权变更进展暨延期复牌的公告
Zheng Quan Zhi Xing· 2025-05-28 10:44
证券代码:002826 证券简称:易明医药 公告编号:2025-033 西藏易明西雅医药科技股份有限公司 关于筹划公司控制权变更进展暨延期复牌的公告 和巨潮资讯网(www.cninfo.com.cn)上披露的《关于筹划公司控制权变更事项 的停牌公告》。 二、进展情况 截至本公告披露日,公司控股股东、实际控制人与相关各方正在积极推动本 次重大事项的各项工作,协议尚未正式签署,公司预计无法在 2025 年 5 月 29 日 (星期四)开市起复牌,根据《深圳证券交易所股票上市规则》《深圳证券交易 所上市公司自律监管指引第 6 号——停复牌》等有关规定,经公司向深圳证券交 易所申请,公司股票(证券简称:易明医药,证券代码:002826)自 2025 年 5 月 29 日(星期四)开市起继续停牌,预计停牌时间不超过 3 个交易日。 停牌期间,公司将根据相关事项进展情况,严格按照法律法规的有关规定及 时履行信息披露义务。公司指定的信息披露媒体为《证券时报》《上海证券报》 及巨潮资讯网(http://www.cninfo.com.cn),待上述事项确定后,公司将及时 发布相关公告并申请复牌。因该事项存在不确定性,敬请投资者 ...
控股股东多次减持后,拟转让控股权!
IPO日报· 2025-05-28 03:55
Core Viewpoint - The company is undergoing a potential change in control as the major shareholder and actual controller, Gao Fan, is planning to transfer control, which has led to a temporary suspension of trading in its shares due to significant uncertainty surrounding the matter [1][2]. Group 1: Shareholder Changes - Gao Fan, the founder of the company, holds 48.80 million shares, accounting for 25.59% of the total share capital, making him the largest shareholder [4]. - Speculation about Gao Fan's exit from the company has been ongoing for several years, especially after he stepped down from key management positions in September 2021 [5]. - Following his resignation, Gao Fan initiated a share reduction plan in June 2022, intending to sell up to 9.56 million shares, which represents 5% of the total share capital [6]. Group 2: Share Reduction History - By the end of the reduction plan in December 2022, Gao Fan had sold 635,800 shares, which is 0.33% of the total share capital [7]. - In February 2023, he announced another reduction plan, aiming to sell up to 5% of the total share capital, but later decided to terminate this plan early in June 2023, having sold 1.5353 million shares, or 0.81% of the total share capital [8]. Group 3: Company Performance - The company has shown lackluster performance since its listing in 2016, with revenues of 602.62 million, 725.46 million, 856.73 million, 667.04 million, and 651.88 million from 2020 to 2024, respectively [12]. - Net profits during the same period were 41.09 million, 43.47 million, 46.12 million, 15.73 million, and 47.46 million, indicating a significant drop in 2023 [12]. - In 2023, the company experienced a 22.14% decline in revenue and a drastic 65.9% drop in net profit, attributed to market conditions and underperformance of acquired subsidiaries [15]. Group 4: Acquisition and Impairment - The company acquired a controlling stake in Inner Mongolia Bostai Enterprise Management Service Co., Ltd. for 30.6 million, but the performance did not meet expectations, leading to a goodwill impairment of approximately 20 million [14].
实控人或从县国资委“升格”市国资委 罗平锌电控股股东策划控制权变更
Mei Ri Jing Ji Xin Wen· 2025-05-27 17:50
每经记者|赵李南 每经编辑|文多 据罗平锌电公告,锌电公司拟向受让方曲靖市发展投资集团有限公司(以下简称曲靖发投)协议转让其 所持有约7243万股上市公司无限售流通股股份,占罗平锌电总股本的22.3960%。 截至今年一季度末,锌电公司持有罗平锌电27.40%的股份。 工商资料显示,曲靖发投的唯一股东为曲靖市国资委。据曲靖发投官网,该公司属曲靖市人民政府授权 曲靖市国资委履行出资人职责的市属国有独资企业,注册资本18.55亿元,下设城市运营投资、水务投 资、产业和金融投资、国有资产运营管理4个功能板块。 罗平锌电表示,本次权益变动的相关事项将根据《上市公司国有股权监督管理办法》的要求,取得有权 国资监管部门的批准或许可后方可进行。 罗平锌电称,由于上述事项尚在筹划中,且尚未签署正式协议,具有重大不确定性。为保证公平信息披 露,避免公司股价异常波动,维护广大投资者利益,经公司向深圳证券交易所申请,公司股票自2025年 5月28日开市起停牌,预计停牌时间不超过2个交易日。 "该事项目前处于筹划阶段,尚存在重大不确定性,敬请广大投资者注意投资风险。"罗平锌电称。 内部控制或得到改善 5月27日,罗平锌电(SZ002 ...
停牌前涨停!002199,拟易主
Zhong Guo Ji Jin Bao· 2025-05-27 15:14
Core Viewpoint - *ST Dongjing is undergoing a potential change in control, with a new investor from the equity investment industry planning to acquire a significant stake, leading to a trading suspension for up to two days starting May 28 [2][6]. Group 1: Control Change Announcement - On May 27, *ST Dongjing announced that its control might change due to negotiations with a third-party investor, which could acquire 25% to 29.99% of the voting rights [6][9]. - The current largest shareholders, Ningbo Meishan Free Trade Port Area Blue Ocean Investment Management Center and shareholder Li Qingyue, hold 10.02% and 6.85% of shares, respectively [6][9]. - The company has no controlling shareholder or actual controller as of the 2024 annual report [6][9]. Group 2: Stock Performance - Following the announcement, *ST Dongjing's stock hit the daily limit up, closing at 6.26 yuan per share, with a total market capitalization of 1.524 billion yuan [2][9]. - The stock's trading volume was reported at 131,600 shares, indicating significant investor interest [4]. Group 3: Financial Performance - For the fiscal year 2024, *ST Dongjing reported an audited revenue of 217 million yuan, with a net loss attributable to shareholders of 73.45 million yuan [11]. - The company has been placed under delisting risk warning since March 26 due to financial performance issues, with a daily price fluctuation limit of 5% [11]. Group 4: Management's Future Plans - The management has denied any plans for equity transfer during a recent earnings call, emphasizing a focus on the core crystal oscillator business and efforts to improve operational efficiency and cost control [9][11]. - The company aims to enhance sales resources and R&D investments to maintain growth and seek new business opportunities [11].
川仪股份: 川仪股份关于控股股东签署《股份转让框架协议的补充协议》《表决权委托协议》暨控制权拟发生变更的进展公告
Zheng Quan Zhi Xing· 2025-05-27 13:13
证券代码:603100 证券简称:川仪股份 公告编号:2025-033 重庆川仪自动化股份有限公司 (一)股份受让方和表决权受托方基本情况 | 名称 | 国机仪器仪表(重庆)有限公司 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 统一社会信用代码 | 91500000MAEAUQPT2T | | | | | | | | 法定代表人 | 周开荃 | | | | | | | | 注册资本 | 20,000 万元人民币 | | | | | | | | 注册地址 | 重庆市两江新区星光大道 62 | 号 C | 区 | 2 | 楼 | 16-1 | 号 | 关于控股股东签署《股份转让框架协议的补充协议》《表决权委托协议》 暨控制权拟发生变更的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 2025 年 5 月 27 日,川仪股份直接控股股东四联集团与国机集团、国机 仪器仪表公司签署《股份转让框架协议的补充协议》,明确由国 ...
濒临退市的A股公司,2亿卖了控股权,接盘方无实控人
梧桐树下V· 2025-05-23 02:48
Core Viewpoint - The article discusses the significant changes in the control of Sailong Pharmaceutical Group Co., Ltd. (*ST Sailong, 002898) following the signing of a share transfer agreement, alongside the company's poor financial performance leading to a delisting risk warning. Group 1: Share Transfer and Control Change - The controlling shareholders, Cai Nanguai and Tang Lin, signed a share transfer agreement to sell 14.16% of the company's shares to Hainan Yayi, amounting to a total transaction value of RMB 199,297,640.00 at a price of RMB 8 per share [1] - Following the transaction, Hainan Yayi will become the controlling shareholder, and the company will have no actual controller since Hainan Yayi currently has no actual controller [1] - The shareholding structure will change significantly, with Cai Nanguai's shareholding dropping from 51.15% to 38.36%, and Tang Lin's from 5.47% to 4.10% [1] Group 2: Financial Performance - Sailong Pharmaceutical reported a revenue of RMB 263.57 million in 2024, a decrease of 15.15% compared to 2023, and a net loss of RMB 33.15 million, a decline of 447.67% year-on-year [2][3] - The company has been issued a delisting risk warning due to its negative net profit and revenue falling below RMB 300 million [3][4] Group 3: Regulatory Actions - The company received a warning letter from the Guangdong Securities Regulatory Bureau due to discrepancies between its earnings forecast and actual performance, as well as failure to disclose potential delisting risks in a timely manner [4][5] - Key executives, including the chairman and financial director, were held responsible for the company's non-compliance with disclosure regulations [5] Group 4: New Shareholder Background - Hainan Yayi, the acquiring entity, was established on May 15, 2025, specifically for this transaction and currently has no actual business operations [6] - The partnership structure of Hainan Yayi indicates that it lacks an actual controller, with decision-making requiring unanimous agreement among partners [8]
*ST赛隆: 关于控股股东、实际控制人签署《股份转让协议》暨公司控制权拟发生变更的提示性公告
Zheng Quan Zhi Xing· 2025-05-19 13:53
证券代码:002898 证券简称:*ST 赛隆 公告编号:2025-026 赛隆药业集团股份有限公司 关于控股股东、实际控制人签署《股份转让协议》 暨公司控制权拟发生变更的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别风险提示: "标的公司") 控股股东、实际控制人蔡南桂先生、唐霖女士于 2025 年 5 月 18 日与海南雅亿共 赢科技合伙企业(有限合伙)(以下简称"海南雅亿") 签署了《关于赛隆药 业集团股份有限公司之股份转让协议》(以下简称《股份转让协议》),蔡南桂 先生、唐霖女士拟向海南雅亿转让其持有的公司 14.16%股份(对应的股票数量 为 24,912,205 股,以下简称"标的股份")。同时,蔡南桂先生、唐霖女士承 诺自本次交易交割日起至其不再持有上市公司股份之日止,无条件且不可撤销地 承诺放弃行使其所持标的公司剩余股份所对应的除收益权和股票处置权之外的 全部股东权利。标的股份作价为人民币 8 元/股,交易金额共计人民币 更。公司的控股股东将变为海南雅亿,由 ...
实控人危机持续发酵!东方材料控制权或再生变
Guo Ji Jin Rong Bao· 2025-05-15 10:56
Core Viewpoint - The control of Dongfang Materials (603110.SH) is shifting due to the judicial auction of shares held by Xu Guangbin, which may lead to a change in the company's major shareholder and actual controller [1][2][3]. Company Overview - Dongfang Materials was established in 1994 and listed on the Shanghai Stock Exchange in 2017, primarily engaged in the production and sales of soft packaging inks, polyurethane adhesives for composites, and PCB electronic inks [4]. - The company has experienced fluctuating performance under Xu Guangbin's leadership, with revenues of 396 million yuan, 404 million yuan, 394 million yuan, and 436 million yuan from 2021 to 2024, and net profits of 56 million yuan, 20 million yuan, 52 million yuan, and 14 million yuan during the same period [16]. Shareholder Changes - Xu Guangbin's shareholding has been subject to multiple judicial auctions, and if the recent auction of 13.5 million shares is completed, his stake will drop to 5.44%, resulting in a new major shareholder, Zhu Junfei, holding 8.84% [1][13]. - The second-largest shareholder will be Jiangsu Teliang New Materials Technology Co., Ltd., with a 5.96% stake [13]. - Xu Guangbin's financial troubles have been highlighted, with overdue debts amounting to approximately 45 million yuan and litigation or arbitration cases totaling about 1.279 billion yuan [13]. Market Performance - As of May 15, Dongfang Materials' stock closed at 17.01 yuan, reflecting a decline of 3.95% and a total market capitalization of 3.423 billion yuan [2]. - The stock price has dropped nearly 50% from around 31 yuan per share in early 2021, indicating significant market depreciation [22]. Future Outlook - The future control of Dongfang Materials remains uncertain, with the potential for Zhu Junfei and Jiangsu Teliang New Materials to influence the company's direction [15][19]. - The company attempted to acquire a 51% stake in Nokia's TD TECH in 2023 but was unsuccessful, and its newly established subsidiary, Dongfang Supercomputing, has reported losses of 915,500 yuan and 4.4671 million yuan in 2023 and 2024, respectively [18].
直击股东大会|控制权“真空”下临时提案获通过 中创环保董事徐秀丽被免
Mei Ri Jing Ji Xin Wen· 2025-05-13 16:10
每经记者|赵李南 每经编辑|魏官红 5月13日,中创环保(SZ300056,股价13.32元,市值51.35亿元)2024年度股东大会召开。 伴随着前实际控制人王光辉、宋安芳夫妇"出局",目前中创环保陷入了控制权"真空期"。 厦门证监局认为,徐秀丽作为时任总经理、时任财务总监、代董事会秘书,未按照《上市公司信息披露 管理办法》第三条的规定履行勤勉尽责义务,对中创环保上述两项违规行为负有主要责任。 今年4月30日,中创环保对2024年度股东大会增加临时提案发布了补充通知。 2021年,徐秀丽辞去总经理职务。 中创环保称,其收到股东邢台辉昇智锋企业管理咨询有限责任公司(以下简称邢台智锋)提交的临时提 案,临时提案的主要内容为免去徐秀丽的非独立董事职务,选举孙成宇为非独立董事。 值得一提的是,徐秀丽在今年4月22日中创环保的董事会上,对多项议案投出了弃权票。 中创环保称,邢台智锋持股比例为4.22%,该提案人的身份符合有关规定,上述临时提案属于股东大会 职权范围,有明确议题和具体决议事项,提案内容及程序符合有关法律、法规和《公司章程》的有关规 定,故公司董事会同意将上述临时提案提交公司2024年年度股东大会审议。 ...